OPTN - OptiNose, Inc.
9.4
0.020 0.213%
Share volume: 7,269
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$9.38
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-11-2023 | 08-10-2023 | 11-09-2023 | 03-07-2024 | 05-14-2024 | 08-08-2024 | 11-12-2024 | 03-26-2025 | |
| Total revenue | 11.846 M | 19.454 M | 19.823 M | 19.864 M | 14.880 M | 20.490 M | 20.437 M | 22.419 M | |
| Cost of revenue | 1.706 M | 2.571 M | 2.225 M | 2.131 M | 1.231 M | 1.981 M | 2.065 M | 1.954 M | |
| Gross profit | 10.140 M | 16.883 M | 17.598 M | 17.733 M | 13.649 M | 18.509 M | 18.372 M | 20.465 M | |
| 66.50% | 4.24% | 0.77% | -23.03% | 35.61% | -0.74% | 11.39% | |||
| Operating expenses | 24.508 M | 21.055 M | 19.292 M | 20.247 M | 21.724 M | 25.057 M | 20.424 M | 20.109 M | |
| Selling general and admin | 22.723 M | 20.104 M | 18.011 M | 18.961 M | 20.518 M | 24.129 M | 19.475 M | 19.337 M | |
| Research and development | 1.785 M | 951.000 K | 1.281 M | 1.286 M | 1.206 M | 928.000 K | 949.000 K | 772.000 K | |
| Total expenses | 26.214 M | 23.626 M | 21.517 M | 22.378 M | 22.955 M | 25.057 M | 20.424 M | 20.109 M | |
| -9.87% | -8.93% | 4.00% | 2.58% | 9.16% | -18.49% | -1.54% | |||
| Operating income | -14.368 M | -4.172 M | -1.694 M | -2.514 M | -8.075 M | -6.548 M | -2.052 M | 356.000 K | |
| Ebit | -14.368 M | -4.172 M | -1.694 M | -2.514 M | -8.075 M | -3.443 M | 4.848 M | 356.000 K | |
| Pretax income | -18.847 M | 2.626 M | -9.294 M | -9.968 M | -14.067 M | -7.581 M | 467.000 K | -12.465 M | |
| -113.93% | -453.92% | 7.25% | 41.12% | -46.11% | -106.16% | -2,769.16% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -18.847 M | 2.626 M | -9.294 M | -9.968 M | -14.067 M | 0.000 | 0.000 | 0.000 | |
| 113.93% | -453.92% | -7.25% | -41.12% | 100.00% | |||||
| Net income | -18.847 M | 2.626 M | -9.294 M | -9.968 M | -14.067 M | -7.581 M | 467.000 K | -360.000 K | |
| 113.93% | -453.92% | -7.25% | -41.12% | 46.11% | 106.16% | -177.09% |
